DK1196403T3 - Antipsykotiske N-aralkylaminer - Google Patents

Antipsykotiske N-aralkylaminer

Info

Publication number
DK1196403T3
DK1196403T3 DK00946022T DK00946022T DK1196403T3 DK 1196403 T3 DK1196403 T3 DK 1196403T3 DK 00946022 T DK00946022 T DK 00946022T DK 00946022 T DK00946022 T DK 00946022T DK 1196403 T3 DK1196403 T3 DK 1196403T3
Authority
DK
Denmark
Prior art keywords
aralkylamines
antipsychotic
Prior art date
Application number
DK00946022T
Other languages
Danish (da)
English (en)
Inventor
Robert Boigegrain
Pierre Lair
Martine Bourrie
Raymond Paul
Martine Poncelet
Jean-Claude Vernieres
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK1196403T3 publication Critical patent/DK1196403T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00946022T 1999-07-02 2000-06-27 Antipsykotiske N-aralkylaminer DK1196403T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9908532A FR2795724B1 (fr) 1999-07-02 1999-07-02 Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
DK1196403T3 true DK1196403T3 (da) 2006-03-20

Family

ID=9547628

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00946022T DK1196403T3 (da) 1999-07-02 2000-06-27 Antipsykotiske N-aralkylaminer

Country Status (31)

Country Link
US (1) US6908914B1 (https=)
EP (1) EP1196403B1 (https=)
JP (1) JP4931309B2 (https=)
KR (1) KR100760446B1 (https=)
CN (1) CN1156462C (https=)
AR (1) AR029374A1 (https=)
AT (1) ATE309231T1 (https=)
AU (1) AU778299B2 (https=)
BG (1) BG65209B1 (https=)
BR (1) BR0012463B1 (https=)
CA (1) CA2376691C (https=)
CO (1) CO5021196A1 (https=)
CZ (1) CZ300936B6 (https=)
DE (1) DE60023898T2 (https=)
DK (1) DK1196403T3 (https=)
EA (1) EA004048B1 (https=)
ES (1) ES2250160T3 (https=)
FR (1) FR2795724B1 (https=)
HK (1) HK1043122A1 (https=)
HR (1) HRP20010949B1 (https=)
HU (1) HU228983B1 (https=)
IL (2) IL147069A0 (https=)
ME (1) MEP25508A (https=)
MX (1) MXPA01013207A (https=)
NO (1) NO322230B1 (https=)
NZ (1) NZ516342A (https=)
RS (1) RS50266B (https=)
TW (1) TWI285640B (https=)
UA (1) UA71009C2 (https=)
WO (1) WO2001002380A1 (https=)
ZA (1) ZA200200018B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE327673T1 (de) * 2001-08-23 2006-06-15 Bayer Cropscience Sa Substituierte propargylamine
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
AU2006308889A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. GABA receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE790971A (fr) * 1971-11-09 1973-05-07 Janssen Pharmaceutica Nv Metode ter voorkoming van patologische reakties die de funktie van het komplement vereisen
JPS504086A (https=) * 1973-01-18 1975-01-16
GB1475314A (en) * 1973-11-02 1977-06-01 Cm Ind Phenyl-propylamine derivatives
US4104383A (en) * 1973-11-02 1978-08-01 C M Industries Derivatives of phenylpropenylamine
EP0347123A3 (en) * 1988-06-17 1991-07-03 Fisons Corporation Dibenzo-cycloheptenyl, -cycloheptyl and -oxepinyl amines having antihistaminic properties
US4855462A (en) * 1988-06-17 1989-08-08 Pennwalt Corporation Antihistamines
US4912222A (en) * 1988-06-17 1990-03-27 Fisons Corporation Antihistamines related to cyproheptadine
FR2663328B1 (fr) * 1990-06-14 1994-08-05 Sanofi Sa Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
AU676993B2 (en) * 1991-06-27 1997-04-10 Virginia Commonwealth University Sigma receptor ligands and the use thereof
JP3199405B2 (ja) * 1991-08-30 2001-08-20 生化学工業株式会社 肝細胞球状集塊化剤及び球状集塊化肝細胞の製造方法
US5486517A (en) * 1994-05-10 1996-01-23 Warner-Lambert Company Benzimidazoles and imidazopyridines as central nervous system agents
FR2751645B1 (fr) 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
CA2284218A1 (en) * 1997-03-18 1998-09-24 Smithkline Beecham P.L.C. Substituted isoquinoline derivatives and their use as anticonvulsants

Also Published As

Publication number Publication date
YU91101A (sh) 2004-09-03
MEP25508A (en) 2010-06-10
WO2001002380A1 (fr) 2001-01-11
NZ516342A (en) 2003-08-29
IL147069A (en) 2006-09-05
HU228983B1 (en) 2013-07-29
BR0012463A (pt) 2002-04-02
EA004048B1 (ru) 2003-12-25
CA2376691C (en) 2009-09-01
FR2795724B1 (fr) 2002-12-13
MXPA01013207A (es) 2002-06-21
PL356186A1 (en) 2004-06-14
AU5992400A (en) 2001-01-22
UA71009C2 (uk) 2004-11-15
HUP0202200A3 (en) 2002-12-28
RS50266B (sr) 2009-07-15
TWI285640B (en) 2007-08-21
IL147069A0 (en) 2002-08-14
HRP20010949A2 (en) 2003-04-30
BG106255A (en) 2002-10-31
BR0012463B1 (pt) 2014-11-04
ATE309231T1 (de) 2005-11-15
AU778299B2 (en) 2004-11-25
CO5021196A1 (es) 2001-03-27
KR20020016877A (ko) 2002-03-06
EA200101209A1 (ru) 2002-06-27
NO20016392D0 (no) 2001-12-27
US6908914B1 (en) 2005-06-21
HUP0202200A2 (en) 2002-10-28
JP4931309B2 (ja) 2012-05-16
HRP20010949B1 (en) 2006-06-30
DE60023898T2 (de) 2006-08-10
EP1196403A1 (fr) 2002-04-17
CA2376691A1 (en) 2001-01-11
DE60023898D1 (de) 2005-12-15
EP1196403B1 (fr) 2005-11-09
ZA200200018B (en) 2003-01-02
CN1367783A (zh) 2002-09-04
NO322230B1 (no) 2006-08-28
KR100760446B1 (ko) 2007-10-04
AR029374A1 (es) 2003-06-25
CN1156462C (zh) 2004-07-07
ES2250160T3 (es) 2006-04-16
NO20016392L (no) 2002-03-04
CZ20014697A3 (cs) 2002-04-17
BG65209B1 (bg) 2007-07-31
WO2001002380A8 (fr) 2001-06-28
JP2003503487A (ja) 2003-01-28
FR2795724A1 (fr) 2001-01-05
HK1043122A1 (zh) 2002-09-06
CZ300936B6 (cs) 2009-09-16

Similar Documents

Publication Publication Date Title
DE60044373D1 (de) Durchflusszytometerprobenbehandlungsverfahren
DE60005976D1 (de) Speicherkkarte
ID26447A (id) Turunan eritropoietin
DE60039942D1 (de) Selbstbräununsschaum
DE19983871T1 (de) Fönvorrichtung
DE10084676T1 (de) Einmallanzettvorrichtung
DE60001240D1 (de) Laserdepiliergerät
DE60001283D1 (de) Celluloseetherfilme
DK1244625T3 (da) 4-pyridinyl-n-acyl-l-phenylalaniner
DE60015794D1 (de) Kompositverschlusskappe
DE60023890D1 (de) Celluligninbrennstoff
DE59909346D1 (de) Zylinderkopfdichtung
DE60012576D1 (de) Spreizfaktorbestimmung
DE60040745D1 (de) Viertorhybrid
ID30214A (id) Turunan resorsinol
DE60022878T2 (de) Konzentrizitätsring
DE50006899D1 (de) Antistatikum
DK1196403T3 (da) Antipsykotiske N-aralkylaminer
DE60013707D1 (de) Flüssigkeitsdosierventil
DE60011488D1 (de) Tuftinggarnauswahlorgan
DE60027753D1 (de) Kompositnadel
DE50001640D1 (de) Nahfeldoptische untersuchungsvorrichtung
DE60012398D1 (de) Alkylformamidtenside
DE50009208D1 (de) Hydroxyphenylvinylthiazole
DE60031136D1 (de) Prozessorarchitectur